NDC 0085-2224 – Noxafil
Posaconazole 300 mg/1 · Powder, For Suspension · Oral
Product NDC0085-2224
Product details
- Brand name
- Noxafil
- Generic name
- Posaconazole
- Labeler
- Merck Sharp & Dohme LLC
- Dosage form
- Powder, For Suspension
- Route
- Oral
- Marketing category
- NDA · NDA214770
- Marketed since
- June 8, 2021
- Listing expires
- December 31, 2027
- Pharmacologic class
- Azole Antifungal
Active ingredients
- Posaconazole 300 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0085-2224-02 | 8 PACKET in 1 CARTON (0085-2224-02) / 1 POWDER, FOR SUSPENSION in 1 PACKET (0085-2224-01) | Jun 8, 2021 |
Recalls mentioning this NDC
- D-0242-2026 Dec 31, 2025 · Class II
Presence of particulate matter: potential presence of metal particulates in the product.